Covered recipient · General Payments record
ANTONIO UCAR
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$8,664.67
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,222.50 | 2 |
| Travel and Lodging | $238.30 | 1 |
| Food and Beverage | $103.04 | 4 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| EISAI INC. | $2,248.30 | 2 |
| Mirati Therapeutics, Inc. | $212.50 | 1 |
| E.R. Squibb & Sons, L.L.C. | $53.52 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $30.74 | 1 |
| ARRAY BIOPHARMA INC | $18.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (7)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ARRAY BIOPHARMA INC | $18.78 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131373490 | CMS |
| E.R. Squibb & Sons, L.L.C. | $28.24 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101565507 | CMS |
| E.R. Squibb & Sons, L.L.C. | $25.28 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101565591 | CMS |
| Eisai Inc. | $2,010.00 | 07/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1110730761 | CMS |
| Eisai Inc. | $238.30 | 07/18/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1110730763 | CMS |
| Mirati Therapeutics, Inc. | $212.50 | 03/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1117172025 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $30.74 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144969202 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.